Abstract 10947: Sacubitril/Valsartan versus Spironolactone in Heart Failure with Preserved Ejection Fraction; A Cost per Outcome Analysis
2021
Introduction: Heart failure with preserved ejection fraction (HFpEF) is associated with frequent hospitalizations and an increased risk of death. There are no therapies with certain benefits for th...
Keywords:
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI